PTEN and neoplasm: In addition to ethnic differences and age factors, many genetic and epigenetic changes are considered to be tumor drivers associated with PCa, including phosphatase and tensin homolog (PTEN) deletion, SPOP mutation, TMPRSS2‐ERG translocation, and Myc amplification.3